2024-21436. Agency Information Collection Activities; Proposed Collection; Comment Request; Labeling Requirements for Prescription Drugs  

  • Table 1—Estimated Annual Recordkeeping Burden 1

    Activity/21 CFR section Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours
    Labeling requirements for prescription drugs; §§ 201.56 and 201.57 414 1.326 549 3,349 1,838,601
    Labeling applicable to medical gas containers; §§ 201.161(b) and 201.328 260 1,663 432,380 0.17 (10 minutes) 73,505
    Exemption from barcode requirements § 201.25(d) 2 1 2 24 48
    Safety labeling required under section 505(o)(4) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), and rebuttal statement 36 1 36 6 216
    Safety labeling changes; posting approved letter on application holder's website 351 1 351 4 1,404
    Exceptions or alternatives to labeling requirements for human drug product held by SNS; § 201.26 1 1 1 32 32
    Hypertension claims; recommended labeling considerations 5 1 5 18 90
    Total 433,324 1,913,896
    1  There are no capital costs or operating and maintenance costs associated with this collection of information.

Document Information

Published:
09/19/2024
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2024-21436
Dates:
Either electronic or written comments on the collection of information must be submitted by November 18, 2024.
Pages:
76853-76855 (3 pages)
Docket Numbers:
Docket No. FDA-2024-N-4167
PDF File:
2024-21436.pdf